A randomized, double-blind, placebo controlled, monocentric study to evaluate the Anti Ageing efficacy and safety of OlepentÂ® cream in Healthy female subjects.

Sami Labs Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1 Female adult subjects in general good health as determined from a recent medical history general physical examination, dermatological assessment.
•2 Subjects in the age group of 35-50 years (both ages inclusive).
•3 Subject with Fitzpatrick skin types III to V.
•4 Subjects having visible fine lines and wrinkles in periorbital area (Crows feet under eye) and forehead
•5 Subject free of excessive hair, acne, cuts, abrasions, fissures, wounds, lacerations, or any other active skin conditions on the face.
•6 Subject who agrees not to use any other product/treatment/home remedy except the provided dove soap bar on their face during the study period other than the test product.
•7 Subjects who agree not to carry out bleaching or any other procedures including facial etc. on face during the study period.
•8 Subjects who agree not to expose to excessive sun light. (Sun exposure not more than half an hour daily and during that time use of umbrella to cover face).
•9 Subjects willing to give a voluntary written informed consent, photography release and agree to come for regular follow up.
•10 Subjects willing to abide by and comply with the study protocol.

•1 Subject with any other signs of significant local irritation or skin disease.
•2 Subject currently taking any medication, which the Investigator believes may influence the interpretation of the data.
•3 Subject having clinically significant systemic or cutaneous disease, chronic illness or had major surgery in the last year.
•4 Subjects who do not agree to remove all jewellery on/around face (e.g. necklace,earrings,if possible nose ring),during VISIA imaging.
•5 Subjects having hairstyle which covers almost the entire forehead.
•6 Subjects undergoing any treatment of any skin condition on their face/forearm.
•7 Subjects not willing to discontinue other topical facial products.
•8 Subject allergic or sensitive to bar cleansing products, cosmetics, creams/lotions, artificial jewellery or anything else.
•9 Pregnant women (as confirmed by UPT) and lactating women.
•10 Subjects on any medical treatment either systemic/topical in the past 1 month or currently taking medication including food supplements.
•11 Subjects with skin allergy history or atopic dermatitis or psoriasis
•12 Subjects who have participated in any other clinical trial in the last 3 months.
•13 Subjects using oral contraceptive pills or hormonal implants as birth control measures during the study
•14 Subjects that was treated with botox/filler /biostimulatory molecules injection.

发起方

Sami Labs Limited